A detailed history of Beacon Pointe Advisors, LLC transactions in Sanofi stock. As of the latest transaction made, Beacon Pointe Advisors, LLC holds 37,880 shares of SNY stock, worth $2.06 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
37,880
Previous 38,789 2.34%
Holding current value
$2.06 Million
Previous $1.88 Million 16.05%
% of portfolio
0.03%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$48.54 - $58.53 $44,122 - $53,203
-909 Reduced 2.34%
37,880 $2.18 Million
Q2 2024

Aug 12, 2024

SELL
$45.39 - $50.36 $66,859 - $74,180
-1,473 Reduced 3.66%
38,789 $1.88 Million
Q1 2024

May 14, 2024

SELL
$45.75 - $52.48 $12,855 - $14,746
-281 Reduced 0.69%
40,262 $1.96 Million
Q4 2023

Feb 08, 2024

SELL
$43.13 - $54.79 $56,327 - $71,555
-1,306 Reduced 3.12%
40,543 $2.02 Million
Q3 2023

Nov 14, 2023

BUY
$50.95 - $55.2 $1.42 Million - $1.53 Million
27,795 Added 197.77%
41,849 $2.24 Million
Q2 2023

Aug 11, 2023

SELL
$50.45 - $57.18 $1.2 Million - $1.36 Million
-23,854 Reduced 62.93%
14,054 $757,000
Q1 2023

May 12, 2023

BUY
$45.86 - $54.45 $1.11 Million - $1.32 Million
24,290 Added 178.37%
37,908 $2.06 Million
Q4 2022

Feb 14, 2023

BUY
$38.86 - $48.55 $30,893 - $38,597
795 Added 6.2%
13,618 $659,000
Q3 2022

Nov 09, 2022

SELL
$37.22 - $100.5 $87,057 - $235,069
-2,339 Reduced 15.43%
12,823 $490,000
Q2 2022

Aug 11, 2022

SELL
$48.99 - $57.46 $15,725 - $18,444
-321 Reduced 2.07%
15,162 $759,000
Q1 2022

May 17, 2022

BUY
$48.48 - $53.65 $87,457 - $96,784
1,804 Added 13.19%
15,483 $795,000
Q4 2021

Feb 14, 2022

BUY
$47.07 - $52.35 $147,376 - $163,907
3,131 Added 29.68%
13,679 $685,000
Q3 2021

Nov 15, 2021

BUY
$47.89 - $53.12 $505,143 - $560,309
10,548 New
10,548 $509,000

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $136B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Beacon Pointe Advisors, LLC Portfolio

Follow Beacon Pointe Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Pointe Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Pointe Advisors, LLC with notifications on news.